ID
35684
Beskrivning
Study ID: 101468/192 Clinical Study ID: 101468/192 Study Title:A 52 Week Open-Label Extension Study of the Long-Term Safety of Ropinirole in Subjects Suffering from Restless Legs Syndrome (RLS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The study consists of 16 visits which are devided in 3 study books: Book 1: Screening (+Baseline), Day 2, Week 1, Week 2 , Week 3 , Week 4, Week 5, Week 6, Week 7, Week 8 Book 2: Week 12, Week 24, Week 36, Week 48, Week 52, Follow-up Book 3: Early withdrawal and Follow-up Each follow-up Visit takes place 7 +/- 3 days after last dose This document contains the Study Medication And Compliance Record form. It has to be filled in for each Visit. It also cntains the Dose reduction due to AE form. It has to be filled in for Week 12-48 and Follow-up.
Nyckelord
Versioner (1)
- 2019-03-15 2019-03-15 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
15 mars 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Long-Term Safety of Ropinirole in Subjects Suffering from Restless Legs Syndrome (RLS), 101468/192
Study Medication And Compliance Record, Dose reduction due to AE
- StudyEvent: ODM
Beskrivning
Study Medication And Compliance Record
Alias
- UMLS CUI-1
- C2734539
- UMLS CUI-2
- C0008972
- UMLS CUI-3
- C1321605
Beskrivning
Week Number
Datatyp
integer
Alias
- UMLS CUI [1,1]
- C0439230
- UMLS CUI [1,2]
- C0237753
Beskrivning
Dose Level
Datatyp
integer
Alias
- UMLS CUI [1]
- C0178602
Beskrivning
day month year
Datatyp
date
Alias
- UMLS CUI [1]
- C3173309
Beskrivning
day month year
Datatyp
date
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C1517741
- UMLS CUI [1,3]
- C0011008
Beskrivning
Number of tablets dispensed
Datatyp
integer
Alias
- UMLS CUI [1,1]
- C0805077
- UMLS CUI [1,2]
- C0304229
Beskrivning
Number of tablets returned
Datatyp
integer
Alias
- UMLS CUI [1,1]
- C2699071
- UMLS CUI [1,2]
- C0304229
Beskrivning
Dose Reductions Due to Adverse Experiences
Alias
- UMLS CUI-1
- C1707814
- UMLS CUI-2
- C0559546
Beskrivning
Week
Datatyp
integer
Alias
- UMLS CUI [1]
- C0439230
Beskrivning
Dose Level
Datatyp
integer
Alias
- UMLS CUI [1]
- C0178602
Beskrivning
day month year
Datatyp
date
Alias
- UMLS CUI [1]
- C3173309
Beskrivning
day month year
Datatyp
date
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C1517741
- UMLS CUI [1,3]
- C0011008
Beskrivning
Number of tablets dispensed
Datatyp
integer
Alias
- UMLS CUI [1,1]
- C0805077
- UMLS CUI [1,2]
- C0304229
Beskrivning
Number of tablets returned
Datatyp
integer
Alias
- UMLS CUI [1,1]
- C2699071
- UMLS CUI [1,2]
- C0304229
Similar models
Study Medication And Compliance Record, Dose reduction due to AE
- StudyEvent: ODM
C0019994 (UMLS CUI [1,2])
C0008972 (UMLS CUI-2)
C1321605 (UMLS CUI-3)
C0237753 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0559546 (UMLS CUI-2)
C1517741 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
Inga kommentarer